258 related articles for article (PubMed ID: 31914198)
21. Medical treatment of endocrine gastroenteropancreatic tumors.
Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R
JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637
[No Abstract] [Full Text] [Related]
22. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
23. Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis.
Pozzari M; Maisonneuve P; Spada F; Berruti A; Amoroso V; Cella CA; Laffi A; Pellicori S; Bertani E; Fazio N
Cancer Treat Rev; 2018 Dec; 71():39-46. PubMed ID: 30352319
[TBL] [Abstract][Full Text] [Related]
24. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
25. Signaling mechanisms in neuroendocrine tumors as targets for therapy.
Zarebczan B; Chen H
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):801-10. PubMed ID: 21095546
[TBL] [Abstract][Full Text] [Related]
26. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
27. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.
Havasi A; Sur D; Cainap SS; Lungulescu CV; Gavrilas LI; Cainap C; Vlad C; Balacescu O
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163032
[TBL] [Abstract][Full Text] [Related]
28. Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.
Wahba A; Delpassand ES; Nunez R; Esfandiari R; Venkatramani R
Pediatr Blood Cancer; 2024 Jun; 71(6):e30961. PubMed ID: 38556730
[No Abstract] [Full Text] [Related]
29. Rare functioning pancreatic endocrine tumors.
O'Toole D; Salazar R; Falconi M; Kaltsas G; Couvelard A; de Herder WW; Hyrdel R; Nikou G; Krenning E; Vullierme MP; Caplin M; Jensen R; Eriksson B; ;
Neuroendocrinology; 2006; 84(3):189-95. PubMed ID: 17312379
[No Abstract] [Full Text] [Related]
30. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
[TBL] [Abstract][Full Text] [Related]
31. Pathologic Classification of Neuroendocrine Neoplasms.
Klimstra DS
Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
[TBL] [Abstract][Full Text] [Related]
32. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
33. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?
Uccella S
Endocr Pathol; 2024 Jun; 35(2):91-106. PubMed ID: 38470548
[TBL] [Abstract][Full Text] [Related]
34. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
Pape UF; Höcker M; Seuss U; Wiedenmann B
Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
[TBL] [Abstract][Full Text] [Related]
35. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.
Angelousi A; Koffas A; Grozinsky-Glasberg S; Gertner J; Kassi E; Alexandraki K; Caplin ME; Kaltsas G; Toumpanakis C
Pancreas; 2019 Aug; 48(7):934-942. PubMed ID: 31268974
[TBL] [Abstract][Full Text] [Related]
37. Principles of diagnosis and management of neuroendocrine tumours.
Raphael MJ; Chan DL; Law C; Singh S
CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
[No Abstract] [Full Text] [Related]
38. The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors.
Batukbhai BDO; De Jesus-Acosta A
Pancreas; 2019 Jan; 48(1):9-21. PubMed ID: 30531241
[TBL] [Abstract][Full Text] [Related]
39. An aggressive neuroendocrine tumour in a man with AIDS.
Cox M; Joseph AT; Sharma N; Heaney O; Hock YL
Int J STD AIDS; 2001 Apr; 12(4):267-9. PubMed ID: 11319980
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic neuroendocrine tumors: current opinions on a rare, but potentially curable neoplasm.
Karakaxas D; Gazouli M; Liakakos T; Vaiopoulou A; Apessou D; Papaparaskeva K; Patapis P; Dervenis C
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):826-35. PubMed ID: 24987821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
